International comparisons of survival from lung cancer: Pitfalls and warnings

Nature Clinical Practice Oncology

Volumn 4, Issue 10, 2007, Pages 570-577

  Erridge, Sara C ^a   Møller, Henrik ^b   Price, Allan ^a   Brewster, David ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CASE FINDING; COMPARATIVE STUDY; DATA ANALYSIS; ETHNICITY; HUMAN; LUNG CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS; SURVIVAL RATE;

DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HUMANS; INTERNATIONALITY; LUNG NEOPLASMS; REGISTRIES; SURVIVAL RATE;

EID: 35148884238     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0932     Document Type: Review

References (75)

1. Gadgeel SM et al. (2001) Impact of race in lung cancer: Analysis of temporal trends from a Surveillance, Epidemiology, and End Results database. Chest 120: 55-63
2. Gregor A et al. (2001) Management and survival of patients with lung cancer in Scotland diagnosed in 1995: Results of a national population based study. Thorax 56: 212-217
3. Black R et al. (1999) Interpretation of population-based cancer survival data. In Cancer survival in Developing Countries (vol 145) 13-17 (Eds Sankaranarayanan R, Black RJ, Parkin DM) Lyon: International Agency for Research on Cancer
4. Capocaccia R et al. (2003) The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 14: 14-27
5. Fry WA et al. (1999) Ten-year survey of lung cancer treatment and survival in hospitals in the United States: A national cancer data base report. Cancer 86: 1867-1876
6. Ries LAG et al. (eds) (2007) SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD [http://seer.cancer.gov/csr/1975_2004/]. Based on November 2006 SEER data submission (accessed August 2007)
7. Butler CA et al. (2005) Do differences in data reporting contribute to variation in lung cancer survival? J Natl Cancer Inst 97: 1385
8. Fu JB et al. (2005) Lung cancer in women: Analysis of the national Surveillance, Epidemiology, and End Results database. Chest 127 768-777
9. Foegle J et al. (2005) Non-small-cell lung cancer in a French department (1982-1997): Management and outcome. Br J Cancer 92 459-466
10. Mennecier B et al. (2003) Women and small cell lung cancer: Social characteristics, medical history, management and survival: A retrospective study of all the male and female cases diagnosed in Bas-Rhin (eastern France) between 1981 and 1994. Lung Cancer 42 141-152
11. Robinson DM et al. (2007) Interpreting international comparisons of cancer survival: The effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 43: 909-913
12. Campling BG et al. (2005) A population-based study of lung carcinoma in Pennsylvania: Comparison of Veterans Administration and civilian populations. Cancer 104: 833-840
13. Cartman ML et al. (2002) Lung cancer: District active treatment rates affect survival. J Epidemiol Community Health 56: 424-429
14. Demeter SJ et al. (2003) The descriptive epidemiology of primary lung cancer in an Alberta cohort with a multivariate analysis of survival to two years. Can Respir J 10: 435-441
15. Laskin JJ et al. (2004) Population-based outcomes for small cell lung cancer: Impact of standard management policies in British Columbia. Lung Cancer 43: 7-16
16. Lebitasy M et al. (2001) Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 85: 808-815
17. Makitaro R et al. (2002) Prospective population-based study on the survival of patients with lung cancer. Eur Respir J 19: 1087-1092
18. Richardson GE et al. (2000) Reported management of lung cancer in Victoria in 1993: Comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust 172: 321-324
19. Vinod SK et al. (2004) Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia. Intern Med J 34: 677-683
20. Stockton D (2001). Cancer survival in Scotland: Understanding social variations [thesis]. London: University of London
21. Bossard N et al. (2006) Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 43: 149-160
22. McDavid K et al. (2003) Cancer survival in Kentucky and health insurance coverage. Arch Intern Med 163: 2135-2144
23. Jack RH et al. (2003) Geographical inequalities in lung cancer management and survival in South East England: Evidence of variation in access to oncology services? Br J Cancer 88: 1025-1031
24. Talback M et al. (2003) Cancer survival in Sweden 1960-1998: developments across four decades. Acta Oncol 42: 637-659
25. Vinod SK et al. (2003) Lung cancer patterns of care in southwestern Sydney, Australia. Thorax 58: 690-694
26. Yeole B (2005) Respiratory cancer population-based survival in Mumbai, India. Asian Pac J Cancer Prev 6: 449-454
27. Janssen-Heijnen ML et al. (2005) Age and co-morbidity in cancer patients: A population-based approach. Cancer Treat Res 124: 89-107
28. Swerdlow AJ et al. (1998) Trends in cancer incidence and mortality in Scotland: Description and possible explanations. Br J Cancer 77 (Suppl 3): S1-S54
29. Janssen-Heijnen M et al. (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 55: 231-240
30. Bach P et al. (1999) Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341: 1198-1205
31. Potosky AL et al. (2004) Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22: 3261-3268
32. Clegg LX et al. (2002) Cancer survival among US whites and minorities: A SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 162: 1985-1993
33. Wisnivesky J et al. (2005) Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 71: 1158-1163
34. Tammemagi CM et al. (2004) In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 57: 597-609
35. Mulligan C et al. (2006) Unlimited access to care: Effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev 15: 25-31
36. Lathan C et al. (2006) The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 24: 413-418
37. Kabat G et al. (1991) Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 81: 1483-1486
38. Shigematsu H et al. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346
39. Tsukuma H et al. (2006) Survival of cancer patients diagnosed between 1993 and 1996: A collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 36: 602-607
40. Coleman MP et al. (2004) Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90 1367-1373
41. Boyd C et al. (1999) Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol 17: 2244-2255
42. Gorey KM et al. (1997) An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan metropolitan areas. Am J Public Health 87: 1156-1163
43. Gorey KM et al. (2000) An international comparison of cancer survival: Relatively poor areas of Toronto, Ontario and three US metropolitan areas. J Public Health Med 22: 343-348
44. Tammemagi CM et al. (2004) Smoking and lung cancer survival: The role of comorbidity and treatment. Chest 125: 27-37
45. Park S et al. (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24 5017-5024
46. Skuladottir H et al. (2006) Does high intake of fruit and vegetables improve lung cancer survival? Lung Cancer 51: 267-273
47. Janssen-Heijnen ML et al. (2001) Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 31: 123-137
48. Devesa SS et al. (2005) International lung cancer trends by Eistologic type: Male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117: 294-299
49. Strand T et al. (2006) Survival after resection for primary lung cancer: A population-based study of 3211 resected patients. Thorax 61: 710-715
50. Goya T et al. (2005) Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study. Lung Cancer 50: 227-234
51. Janssen-Heijnen M et al. (2001) Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung? Epidemiology 12: 256-258
52. Janssen-Heijnen M et al. (1998) Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975. Br J Cancer 77: 2053-2057
53. Brooks D et al. (2007) Temporal trends in non-small cell lung cancer survival in Sweden. Br J Cancer 96: 519-522
54. Fergusson RJ et al. (2003) Lung cancer: The importance of seeing a respiratory physician. Eur Respir J 21: 606-610
55. Yanagisawa K et al. (2003) Molecular fingerprinting in human lung cancer. Clin Lung Cancer 5: 113-118
56. Meyerson M et al. (2005) Genomic and proteomic profiling of lung cancers: Lung cancer classification in the age of targeted therapy. J Clin Oncol 23: 3219-3226
57. Zhu C et al. (2006) Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59: 790-800
58. Xi L et al. (2005) Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res 11: 4128-4135
59. Moran CJ et al. (2002) RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res 8: 3803-3812
60. Potti A et al. (2006) A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355: 570-580
61. Feinstein A et al. (1985) The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312: 1604-1608
62. Storm H et al. (1999) Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J 13: 430-435
63. Aragoneses F et al. (2002) Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 36 59-63
64. Bozcuk H et al. (2001) Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 34: 243-252
65. Quarterman R et al. (2003) Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 125: 108-113
66. Buccheri G et al. (2004) Lung cancer: Clinical presentation and specialist referral time. Eur Respir J 24: 898-904
67. Myrdal G et al. (2004) Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 59: 45-49
68. Marcus P et al. (2000) Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. J Natl Cancer Inst 92 1308-1316
69. Henschke C et al. (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355: 1763-1771
70. Patz EJ et al. (2004) Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: Implications for current mass screening recommendations. J Clin Oncol 22: 2202-2206
71. Ramalingam S et al. (1998) Lung cancer in young patients: Analysis of a Surveillance, Epidemiology, and End Results database. J Clin Oncol 16: 651-657
72. Mahmud SM et al. (2003) Patterns of initial management of lung cancer in the Republic of Ireland: A population-based observational study. Lung Cancer 41: 57-64
73. Barbera L et al. (2003) Defining the need for radiotherapy for lung cancer in the general population: A criterion-based, benchmarking approach. Med Care 41: 1074-1085
74. Delaney G et al. (2003) A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 4: 120-128
75. Erridge S et al. (2005) Lung cancer in South-East Scotland: Has treatment and survival improved since 1995? Lung Cancer 49 (Suppl 2): S200